China Resources Double-Crane Pharmaceutical Co., Ltd. at its special shareholders' meeting of 2014 on June 25, 2014, which discussed and approved the proposal of Zhang Wenzhou's resignation from the position of Independent Director and the proposal of recommendation of Wu Zhi'ang Independent Director.